# Autolus Therapeutics plc American Depositary Share (AUTL) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare / Biotechnology. Price $2.24, market value $596 million.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Autolus Therapeutics plc American Depositary Share reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 5.1×**. Each dollar of revenue is priced at 5.1×.
- **Price / book: 0.4×**. The shares trade below book value, which can signal a bargain or a balance sheet the market doubts.
- **Free-cash-flow yield: -39.3%** (5-yr avg -42.3%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Operating margin: -210.8%**. Operating margin is negative: the business loses money before interest and tax.
- **Net margin: -381.4%**. The company reported a net loss over the last twelve months.
- **Return on equity: -161.4%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: -264.2%**. Return on all capital, debt included, is -264.2%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: -47.6%**. Each dollar of assets produces -47.6% of profit.

## Growth
- **Revenue growth (1 yr): 644.9%**. Revenue grew 644.9% over the last year.
- **EPS growth (1 yr): -25.6%**. Earnings per share fell 25.6%, slower than revenue, so margins compressed.

## Financial health
- **Debt to equity: 0.00**. Debt is 0.00 times equity: a conservative balance sheet.
- **Net debt / EBITDA: 0.4×**. It would take 0.4 years of operating earnings to repay net borrowings, within the comfortable range.
- **Current ratio: 5.94** (quick 5.94). Current assets cover the next year's liabilities 5.94 times.
- **Altman Z-score: 0.64**. A Z-score of 0.64 is in the distress zone, a signal to examine the balance sheet closely.
- **Piotroski F-score: 3/9**. 3 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. Autolus Therapeutics plc American Depositary Share does not currently pay a dividend.

## Analyst view
- **Analyst consensus: strong_buy** (8 analysts). 8 analysts cover Autolus Therapeutics plc American Depositary Share; the consensus is strong_buy, with an average price target of $8.72 (+290% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 54.5%** (YTD 12.6%, 3-mo 46.4%). The shares are up 54.5% over twelve months including dividends.
- **From 52-week high: -13.2%** (90.6% above the low). Trading 13% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 54**. An RSI of 54 is neutral.
- **Beta (1 yr): 1.83** (volatility 79%). Beta of 1.83 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=AUTL · Page: https://foliofundamentals.com/stocks/autl

Not investment advice.